Biological factors that affect CD95 ligand-mediated inflammation.
暂无分享,去创建一个
[1] K. Okumura,et al. Antitumor effect of locally produced CD95 ligand , 1997, Nature Medicine.
[2] C. Ricordi,et al. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection. , 1996, Transplantation.
[3] K. Okumura,et al. Contribution of Fas ligand to cardiac allograft rejection. , 1996, International immunology.
[4] C. Stoeckert,et al. Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice , 1996, Science.
[5] K. Okumura,et al. CD95 ligand in graft rejection , 1996, Nature.
[6] D. Bellgrau,et al. A role for CD95 ligand in preventing graft rejection , 1995, Nature.
[7] S. Nagata,et al. The Fas death factor , 1995, Science.